Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
J Craniomaxillofac Surg ; 43(10): 2071-7, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26776291

ABSTRACT

PURPOSE: The aim of this study was to investigate local blood flow changes in the mandibular bone compared to the os frontale after irradiation in various doses. MATERIALS AND METHODS: This study used an animal experiment with 16 female Göttingen minipigs. Three groups of four animals were irradiated with equivalent doses of 25, 50 or 70 Gray on the mandible and os frontale and four animals served as control. Three months after irradiation laser Doppler flowmetry (LDF) was used to record local blood flow on the left mandible and in the irradiated area on the os frontale. At 6 months measurements were repeated. Descriptive and univariate analyses were conducted and p-values lower than 0.05 were considered statistically significant. RESULTS: Local blood flow measurements in the mandible were significantly higher compared to the os frontale. In the os frontale and mandible there was no significant change in the measurements with increasing irradiation dose. CONCLUSION: We found a non-significant decrease in LDF values with an increase in radiation dose in the mandible and non-significant changes in the os frontale at 3 and 6 months. We consider this to represent the process of on-going fibrosis affecting the local blood flow in the mandible.


Subject(s)
Frontal Bone/blood supply , Laser-Doppler Flowmetry/methods , Mandible/blood supply , Regional Blood Flow , Animals , Female , Frontal Bone/radiation effects , Mandible/radiation effects , Swine , Swine, Miniature
2.
Am J Dermatopathol ; 35(3): 395-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23095341

ABSTRACT

Malignant chondroid syringoma is a very rare type of malignant sweat gland tumor. Diagnosis is based on pathologic features but is complicated by the low frequency of this tumor. The authors report a new case of malignant chondroid syringoma, initially misdiagnosed as basal cell carcinoma, that exhibited very aggressive local behavior and was located on the face, a rare site for this tumor. The authors describe its histopathologic appearance and highlight the importance of including adenoid cystic carcinoma in the differential diagnosis.


Subject(s)
Adenoma, Pleomorphic/pathology , Ethmoid Bone/pathology , Facial Neoplasms/pathology , Frontal Bone/pathology , Sweat Gland Neoplasms/pathology , Adenoma, Pleomorphic/diagnostic imaging , Adenoma, Pleomorphic/radiotherapy , Adenoma, Pleomorphic/surgery , Aged, 80 and over , Biopsy , Carcinoma, Adenoid Cystic/pathology , Carcinoma, Basal Cell/pathology , Diagnosis, Differential , Diagnostic Errors , Ethmoid Bone/diagnostic imaging , Ethmoid Bone/radiation effects , Ethmoid Bone/surgery , Facial Neoplasms/diagnostic imaging , Facial Neoplasms/radiotherapy , Facial Neoplasms/surgery , Frontal Bone/diagnostic imaging , Frontal Bone/radiation effects , Frontal Bone/surgery , Humans , Male , Neoplasm Invasiveness , Osteotomy , Predictive Value of Tests , Radiotherapy, Adjuvant , Plastic Surgery Procedures , Sweat Gland Neoplasms/diagnostic imaging , Sweat Gland Neoplasms/radiotherapy , Sweat Gland Neoplasms/surgery , Tomography, X-Ray Computed
3.
J Calif Dent Assoc ; 34(9): 711-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17022295

ABSTRACT

Osseointegrated implants can be applied to facilitate retention, stability, and support for facial and intraoral prostheses used to restore head and neck defects. At the University of California, Los Angeles, Maxillofacial Prosthetics Clinic, retrospective studies have indicated that in nonirradiated maxillectomy patients, implant survival rates are 82.6 percent. In mandibles reconstructed with fibula free flaps, survival rates are 94.6 percent. Similarly, high implant survival rates have been observed for most sites used to support facial prostheses. Cumulative six-year survival rates for auricular sites exceed 95 percent and for floor of nose sites, success rates exceed 87 percent. However, survival rates are low (53 percent) for implants placed in the frontal bone for retention of orbital prostheses and even lower for irradiated bone sites ranging from 63 percent in the maxilla to 27 percent in the orbit.


Subject(s)
Dental Implantation, Endosseous , Facial Bones/surgery , Osseointegration/physiology , Prosthesis Implantation , Bone Transplantation , Ear, External , Face/surgery , Frontal Bone/radiation effects , Frontal Bone/surgery , Humans , Hyperbaric Oxygenation , Mandible/surgery , Mastication/physiology , Maxilla/radiation effects , Maxilla/surgery , Nasal Cavity/surgery , Orbit/radiation effects , Orbit/surgery , Osteoradionecrosis/physiopathology , Palatal Obturators , Radiotherapy Dosage , Plastic Surgery Procedures , Retrospective Studies , Surgical Flaps , Survival Analysis , Treatment Outcome
4.
J Gastroenterol Hepatol ; 20(3): 488-92, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15740500

ABSTRACT

Spontaneous regression of hepatocellular carcinoma (HCC) is a rare phenomenon. This case of a 65-year-old Korean man with HCC and metastatic frontal bone mass that regressed after radiotherapy for frontal bone mass without any other therapeutic modalities is described. The clinical diagnosis of HCC was made because of the presence of a liver mass on abdominal computed tomography (CT) scan, high serum alpha-fetoprotein value and tissue diagnosis on frontal bone biopsy. The patient refused any other recommended treatments, but accepted the radiation therapy due to a painful frontal bone mass, and ingested mushroom called Phellinus linteus for one and a half years. Ten months after radiation therapy, he experienced a reduction in size of the frontal bone mass and improvement of lesions in the liver, sternum and ribs. The patient is alive and in good condition without any symptoms or tumor aggravation in August 2002. It was concluded that a rare case of spontaneous regression of HCC had occurred.


Subject(s)
Carcinoma, Hepatocellular/secondary , Liver Neoplasms/pathology , Neoplasm Regression, Spontaneous , Skull Neoplasms/secondary , Aged , Biopsy , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/radiotherapy , Follow-Up Studies , Frontal Bone/pathology , Frontal Bone/radiation effects , Humans , Liver Neoplasms/diagnostic imaging , Male , Skull Neoplasms/pathology , Skull Neoplasms/radiotherapy , Time Factors , Tomography, X-Ray Computed
5.
Clin Nucl Med ; 21(12): 960-3, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8957612

ABSTRACT

A 50-year-old man had metastatic pheochromocytoma to the left frontal bone. The primary adrenal tumor was removed 12 years previously. Bone scanning and diagnostic I-131 and I-123 MIBG imaging showed metastatic lesions in the right femur and midthoracic spine. However, post-therapy I-131 MIBG scanning showed extensive and widespread metastatic disease. Post-therapeutic I-131 MIBG whole-body scanning was necessary to more fully assess the extent of metastatic pheochromocytoma.


Subject(s)
Adrenal Gland Neoplasms/pathology , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/secondary , Iodine Radioisotopes , Iodobenzenes , Pheochromocytoma/diagnostic imaging , Pheochromocytoma/secondary , Radiopharmaceuticals , 3-Iodobenzylguanidine , Antineoplastic Agents/therapeutic use , Bone Neoplasms/radiotherapy , Femoral Neoplasms/diagnostic imaging , Femoral Neoplasms/radiotherapy , Femoral Neoplasms/secondary , Frontal Bone/diagnostic imaging , Frontal Bone/radiation effects , Humans , Iodine Radioisotopes/therapeutic use , Iodobenzenes/therapeutic use , Male , Middle Aged , Pheochromocytoma/radiotherapy , Radionuclide Imaging , Radiopharmaceuticals/therapeutic use , Radiotherapy Dosage , Skull Neoplasms/diagnostic imaging , Skull Neoplasms/radiotherapy , Skull Neoplasms/secondary , Spinal Neoplasms/diagnostic imaging , Spinal Neoplasms/radiotherapy , Spinal Neoplasms/secondary , Thoracic Vertebrae/diagnostic imaging , Thoracic Vertebrae/radiation effects , Whole-Body Counting
7.
Zentralbl Allg Pathol ; 134(1): 41-5, 1988.
Article in German | MEDLINE | ID: mdl-3162784

ABSTRACT

Two cases of radiation-induced sarcomas are presented. Osteosarcomas developed in the frontal bone after a latency period of 36 years following operation for brain tumor with post-operative irradiation (48 Gy) in one patient and in the region of the right sacro-iliac joint after ablation of testis for seminoma with post-operative irradiation (60 Gy) in another patient. In the literature, the risk of developing an irradiation-induced sarcoma is considered to be low (0.05-0.2%). Both cases, however, underline the necessity of an exact indication for irradiation to avoid such complications.


Subject(s)
Bone Neoplasms/pathology , Frontal Bone/pathology , Ilium/pathology , Neoplasms, Radiation-Induced/pathology , Osteosarcoma/pathology , Skull Neoplasms/pathology , Adolescent , Adult , Brain Neoplasms/radiotherapy , Combined Modality Therapy , Dysgerminoma/radiotherapy , Frontal Bone/radiation effects , Humans , Ilium/radiation effects , Male , Testicular Neoplasms/radiotherapy
SELECTION OF CITATIONS
SEARCH DETAIL
...